Patrick R. Trucchio
Stock Analyst at HC Wainwright & Co.
(4.63)
# 199
Out of 5,139 analysts
46
Total ratings
63.04%
Success rate
25.56%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick R. Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DRUG Bright Minds Biosciences | Reiterates: Buy | $115 | $88.00 | +30.68% | 3 | Dec 30, 2025 | |
| VIR Vir Biotechnology | Reiterates: Buy | $15 | $6.06 | +147.52% | 2 | Dec 30, 2025 | |
| ASMB Assembly Biosciences | Reiterates: Buy | $50 | $29.37 | +70.24% | 2 | Dec 22, 2025 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $40 | $2.27 | +1,662.11% | 4 | Dec 16, 2025 | |
| MRKR Marker Therapeutics | Initiates: Buy | $10 | $1.81 | +452.49% | 1 | Dec 8, 2025 | |
| PHVS Pharvaris | Reiterates: Buy | $60 | $25.09 | +139.14% | 3 | Dec 3, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Buy | $80 → $85 | $63.84 | +33.15% | 3 | Dec 2, 2025 | |
| HRMY Harmony Biosciences Holdings | Reiterates: Buy | $55 | $36.22 | +51.85% | 2 | Nov 24, 2025 | |
| ONCY Oncolytics Biotech | Maintains: Buy | $5 → $10 | $1.01 | +890.10% | 1 | Nov 17, 2025 | |
| VYGR Voyager Therapeutics | Maintains: Buy | $30 → $25 | $3.76 | +564.89% | 2 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $16.99 | +106.00% | 1 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $70 | $22.84 | +206.48% | 5 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $10 | $2.45 | +308.16% | 3 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $50 | $17.17 | +191.21% | 2 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $33.35 | +199.85% | 1 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $4.24 | +183.02% | 2 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $31.22 | +156.25% | 2 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $570 | $359.27 | +58.66% | 2 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $3.64 | +312.09% | 1 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $5.04 | +1,388.10% | 1 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $7.94 | +529.72% | 2 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.40 | +2,391.28% | 1 | Sep 4, 2025 |
Bright Minds Biosciences
Dec 30, 2025
Reiterates: Buy
Price Target: $115
Current: $88.00
Upside: +30.68%
Vir Biotechnology
Dec 30, 2025
Reiterates: Buy
Price Target: $15
Current: $6.06
Upside: +147.52%
Assembly Biosciences
Dec 22, 2025
Reiterates: Buy
Price Target: $50
Current: $29.37
Upside: +70.24%
NRx Pharmaceuticals
Dec 16, 2025
Reiterates: Buy
Price Target: $40
Current: $2.27
Upside: +1,662.11%
Marker Therapeutics
Dec 8, 2025
Initiates: Buy
Price Target: $10
Current: $1.81
Upside: +452.49%
Pharvaris
Dec 3, 2025
Reiterates: Buy
Price Target: $60
Current: $25.09
Upside: +139.14%
Arrowhead Pharmaceuticals
Dec 2, 2025
Maintains: Buy
Price Target: $80 → $85
Current: $63.84
Upside: +33.15%
Harmony Biosciences Holdings
Nov 24, 2025
Reiterates: Buy
Price Target: $55
Current: $36.22
Upside: +51.85%
Oncolytics Biotech
Nov 17, 2025
Maintains: Buy
Price Target: $5 → $10
Current: $1.01
Upside: +890.10%
Voyager Therapeutics
Nov 12, 2025
Maintains: Buy
Price Target: $30 → $25
Current: $3.76
Upside: +564.89%
Nov 10, 2025
Maintains: Buy
Price Target: $40 → $35
Current: $16.99
Upside: +106.00%
Nov 4, 2025
Maintains: Buy
Price Target: $110 → $70
Current: $22.84
Upside: +206.48%
Nov 3, 2025
Maintains: Buy
Price Target: $5 → $10
Current: $2.45
Upside: +308.16%
Oct 24, 2025
Maintains: Buy
Price Target: $10 → $50
Current: $17.17
Upside: +191.21%
Oct 22, 2025
Reiterates: Buy
Price Target: $100
Current: $33.35
Upside: +199.85%
Oct 20, 2025
Reiterates: Buy
Price Target: $12
Current: $4.24
Upside: +183.02%
Oct 10, 2025
Reiterates: Buy
Price Target: $80
Current: $31.22
Upside: +156.25%
Oct 10, 2025
Reiterates: Buy
Price Target: $570
Current: $359.27
Upside: +58.66%
Sep 23, 2025
Reiterates: Buy
Price Target: $15
Current: $3.64
Upside: +312.09%
Sep 16, 2025
Reiterates: Buy
Price Target: $75
Current: $5.04
Upside: +1,388.10%
Sep 12, 2025
Reiterates: Buy
Price Target: $50
Current: $7.94
Upside: +529.72%
Sep 4, 2025
Reiterates: Buy
Price Target: $10
Current: $0.40
Upside: +2,391.28%